September 13, 2011in Patents, Pharmaceutical Drugs1by Editor292 Proposed Revisions To PM(NOC) Regulations Aim To Reduce Redundancy Dan Whalen is a JD candidate at Osgoode Hall Law School. On August 17, 2011, Health Canada released proposed revisions to its Guidance Document: Patented Medicines (Notice of Compliance) Regulations…
